| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 68.75M | 58.51M | 77.20M | 130.39M | 91.94M | 170.35M |
| Gross Profit | 14.89M | 15.38M | 23.95M | 31.35M | 11.17M | 19.10M |
| EBITDA | -80.29M | -79.42M | -31.91M | -21.94M | -31.05M | -22.75M |
| Net Income | -86.57M | -86.37M | -40.45M | -32.34M | -46.75M | -34.10M |
Balance Sheet | ||||||
| Total Assets | 103.88M | 104.59M | 190.27M | 231.82M | 274.64M | 333.50M |
| Cash, Cash Equivalents and Short-Term Investments | 628.00K | 308.00K | 507.00K | 1.32M | 2.68M | 218.00K |
| Total Debt | 45.57M | 47.66M | 60.08M | 99.67M | 125.11M | 164.18M |
| Total Liabilities | 166.61M | 158.69M | 155.03M | 178.20M | 191.61M | 209.51M |
| Stockholders Equity | -62.73M | -54.10M | 35.24M | 53.62M | 83.02M | 123.99M |
Cash Flow | ||||||
| Free Cash Flow | -3.40M | 3.71M | 13.65M | 9.63M | -2.00M | -18.36M |
| Operating Cash Flow | -3.40M | 3.71M | 13.65M | 9.66M | 1.96M | -18.31M |
| Investing Cash Flow | 1.00K | 1.00K | 2.00K | -24.00K | 30.28M | 4.80M |
| Financing Cash Flow | 2.33M | -4.17M | -13.46M | -9.41M | -27.78M | 751.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$139.00M | 5.92 | 10.51% | ― | 14.65% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$144.63M | 2.02 | 11.61% | ― | 5.34% | 43.91% | |
53 Neutral | HK$198.91M | 61.25 | 0.62% | 2.34% | -48.30% | -75.98% | |
49 Neutral | HK$912.98M | -160.64 | -3.68% | ― | -0.28% | -469.70% | |
45 Neutral | HK$200.52M | -0.47 | -46.79% | ― | 0.26% | 69.65% | |
38 Underperform | HK$48.93M | -0.44 | ― | ― | 1.43% | -83.97% |
Anchorstone Holdings Limited plans to increase its authorised share capital from HK$50 million to HK$400 million by creating an additional 3.5 billion shares, all ranking pari passu with existing shares, subject to shareholder approval at an extraordinary general meeting. The company is also launching a non-underwritten rights issue on the basis of four rights shares for every one existing share at HK$0.105 per rights share, seeking to raise up to about HK$121.6 million before set-off and expenses, with estimated net proceeds of up to approximately HK$62.5 million depending on shareholder take-up. Rights shares will be provisionally allotted to qualifying shareholders only, will rank equally with existing shares and entitle holders to future distributions, while any unsubscribed or excluded shareholders’ rights shares will be placed to independent investors on a best-effort basis, with any remaining unsold shares not being issued and the rights issue size reduced accordingly. As the issue is non-underwritten and has no minimum subscription, the company has built in a scaling-down mechanism to prevent any shareholder, other than HKSCC Nominees, from unintentionally triggering a mandatory general offer under the Takeovers Code, reflecting a cautious approach to capital-raising that balances funding needs with regulatory and shareholder considerations.
The most recent analyst rating on (HK:1592) stock is a Sell with a HK$0.19 price target. To see the full list of analyst forecasts on Anchorstone Holdings Limited stock, see the HK:1592 Stock Forecast page.
Anchorstone Holdings Limited has disclosed that a winding-up petition has been filed by Hang Chin Marble Engineering Limited against its indirectly wholly owned subsidiary, Pacific Marble and Granite Limited, alleging insolvency over an unpaid judgment debt of about HK$9 million arising from prior construction and arbitration proceedings. The petition is scheduled to be heard on 11 February 2026, and while the company is currently seeking legal advice, its board maintains that the disputed amount is not expected to have a material adverse impact on the group’s overall operations or financial position, though shareholders and potential investors are urged to exercise caution pending further updates.
The most recent analyst rating on (HK:1592) stock is a Sell with a HK$0.19 price target. To see the full list of analyst forecasts on Anchorstone Holdings Limited stock, see the HK:1592 Stock Forecast page.
Anchorstone Holdings Limited has announced a change of auditors, following the resignation of Rongcheng (Hong Kong) CPA Limited, which cited considerations such as professional risks, internal resources and audit fees in deciding not to continue its engagement. The board, upon the recommendation of the audit committee, has appointed Guangshen (Hong Kong) CPA Limited as the new auditor with effect from 29 December 2025, filling the casual vacancy until the next annual general meeting; the company emphasized that there are no other matters related to the change requiring shareholders’ attention, signaling an orderly transition in its audit oversight rather than a dispute-driven departure.
The most recent analyst rating on (HK:1592) stock is a Sell with a HK$0.19 price target. To see the full list of analyst forecasts on Anchorstone Holdings Limited stock, see the HK:1592 Stock Forecast page.
Anchorstone Holdings Limited has announced a clarification regarding the appointment of Prof. Jiang Zhihong as an Independent Non-Executive Director and a member of the audit committee. The company corrected a clerical error in the previous announcement, specifying that Prof. Jiang has been serving as an independent non-executive director of Shanghai Haohai Biological Technology Co., Ltd since May 2020. This appointment is expected to enhance the company’s governance and oversight capabilities.
The most recent analyst rating on (HK:1592) stock is a Hold with a HK$0.25 price target. To see the full list of analyst forecasts on Anchorstone Holdings Limited stock, see the HK:1592 Stock Forecast page.
Anchorstone Holdings Limited has announced the composition of its board of directors and their respective roles. The board consists of executive directors and independent non-executive directors, with specific members chairing the Audit, Remuneration, and Nomination Committees. This announcement provides clarity on the governance structure of the company, potentially impacting its strategic decision-making and stakeholder confidence.
The most recent analyst rating on (HK:1592) stock is a Hold with a HK$0.25 price target. To see the full list of analyst forecasts on Anchorstone Holdings Limited stock, see the HK:1592 Stock Forecast page.
Anchorstone Holdings Limited has announced the composition of its board of directors and the roles of each member. The board consists of executive directors, including Chairman Lui Yue Yun Gary, and independent non-executive directors. The company has also detailed the members of its three board committees: Audit, Remuneration, and Nomination. This announcement provides clarity on the governance structure of the company, potentially impacting its strategic decision-making and offering insights into its corporate governance practices.
The most recent analyst rating on (HK:1592) stock is a Hold with a HK$0.33 price target. To see the full list of analyst forecasts on Anchorstone Holdings Limited stock, see the HK:1592 Stock Forecast page.
Anchorstone Holdings Limited has announced the appointment of Prof. Jiang Zhihong as an independent non-executive director, effective from December 10, 2025. Prof. Jiang brings over 30 years of experience in natural product chemistry and Chinese medicine quality research, which could enhance the company’s strategic direction and industry positioning. His extensive academic and professional background, including his roles at Macau University of Science and Technology, is expected to provide valuable insights and leadership to the board.
The most recent analyst rating on (HK:1592) stock is a Hold with a HK$0.33 price target. To see the full list of analyst forecasts on Anchorstone Holdings Limited stock, see the HK:1592 Stock Forecast page.
Anchorstone Holdings Limited has successfully completed the placement of 48,259,000 new shares, representing approximately 16.67% of its enlarged share capital, at a price of HK$0.25 per share. The placement raised gross proceeds of approximately HK$12.06 million, with net proceeds estimated at HK$11.78 million. The funds will be allocated towards repaying bank loans, settling other debts, and general working capital. This strategic move is expected to strengthen the company’s financial position and support its operational needs.
The most recent analyst rating on (HK:1592) stock is a Hold with a HK$0.33 price target. To see the full list of analyst forecasts on Anchorstone Holdings Limited stock, see the HK:1592 Stock Forecast page.
Anchorstone Holdings Limited, along with its subsidiaries, has entered into a third supplemental placing agreement to extend the date for the completion of the placing of new shares under a general mandate. The new extended date is set for 5 December 2025, allowing more time for the fulfillment of conditions under the placing agreement. This extension indicates the company’s efforts to ensure the successful completion of the share placement, which may impact its financial strategy and market positioning.
The most recent analyst rating on (HK:1592) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Anchorstone Holdings Limited stock, see the HK:1592 Stock Forecast page.